Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers in 2026
Mar 25 2026
Multiple System Atrophy: Understanding Parkinsonian Features and Poor Prognosis
Multiple System Atrophy (MSA-P) is a rare, aggressive neurological disorder with parkinsonian symptoms and severe autonomic failure. Unlike Parkinson’s, it progresses rapidly, responds poorly to treatment, and has a median survival of only 6-10 years.
